EuKedos S.p.A. (BIT:EUK)
Italy · Delayed Price · Currency is EUR 0.6950
+0.0050 (0.72%)
At close: Feb 11, 2026
EuKedos Revenue
EuKedos had revenue of 25.79M EUR in the half year ending June 30, 2025, with 9.13% growth. This brings the company's revenue in the last twelve months to 52.60M, up 3.76% year-over-year. In the year 2024, EuKedos had annual revenue of 51.69M with 4.53% growth.
Revenue (ttm)
52.60M
Revenue Growth
+3.76%
P/S Ratio
0.30
Revenue / Employee
76.57K
Employees
687
Market Cap
15.81M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 51.69M | 2.24M | 4.53% |
| Dec 31, 2023 | 49.45M | 2.41M | 5.12% |
| Dec 31, 2022 | 47.04M | 1.86M | 4.12% |
| Dec 31, 2021 | 45.18M | -1.81M | -3.85% |
| Dec 31, 2020 | 46.99M | -6.37M | -11.94% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.55B |
| Amplifon | 2.41B |
| DiaSorin | 1.21B |
| EL.En. | 580.41M |
| GPI S.p.A. | 531.42M |
| Svas Biosana | 134.95M |
| Talea Group | 132.17M |
| Farmacosmo | 59.23M |